LINEAGE CELL THERAPEUTICS IN (LCTX)
US53566P1093 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.34M 137.16% | 14.7M 238.71% | 8.945M -39.15% | 5.324M -40.48% | 11.9M 123.52% | 25.717M 116.11% | 43.133M 67.72% | 95.937M 122.42% | 159.51M 66.27% | 255.67M 60.28% | 382.61M 49.65% | |
| EBITDA YoY % growth | -48.34M -98.68% | -21.79M 54.92% | -24.041M -10.33% | -26.632M -10.78% | -21.4M 19.65% | -17.595M 17.78% | -25.475M -44.78% | -26.994M -5.97% | -22.165M 17.89% | -17.564M 20.75% | -18.952M -7.90% | |
| EBIT YoY % growth | -49.21M -86.05% | -22.52M 54.24% | -24.733M -9.83% | -24.213M 2.10% | -30.23M -24.85% | -31.531M -4.31% | -1.077M 96.59% | 43.62M 4,151.61% | 102.06M 133.98% | 193.09M 89.19% | 304.9M 57.91% | |
| Operating Margin | -1,133.87% | -153.20% | -276.50% | -454.80% | -254.03% | -122.61% | -2.50% | 45.47% | 63.98% | 75.52% | 79.69% | |
| EPS YoY % growth | -0.26 -85.71% | -0.15 42.31% | -0.13 13.33% | -0.13 -2.00% | -0.15 -12.82% | -0.16 -9.09% | -0.14 12.50% | -0.15 -7.14% | -0.05 66.67% | 0.01 110.00% | 0.32 6,200.00% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.04 -24.68% | -0.04 -8.38% | -0.04 -44.50% | -0.04 -104.00% | -0.02 52.28% | -0.05 -17.65% | -0.05 -17.65% | -0.05 -25.00% | -0.05 -185.71% |
| Revenue Q2Q % growth | 1.422M -31.90% | 1.04M -27.98% | 1.04M -26.14% | 1.04M -72.48% | 6.14M 331.79% | 1.377M 32.40% | 1.377M 32.40% | 1.377M 32.40% | 1.377M -77.57% |
| EBITDA Q2Q % growth | -6.793M -19.81% | -6.916M -6.62% | -7.028M -26.63% | -7.109M -110.21% | -7.15M -5.26% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.512M -18.08% | -8.813M -32.30% | -9.042M -54.12% | -9.339M -143.20% | -4.667M 37.88% | -9.402M -6.69% | -9.912M -9.63% | -10.422M -11.60% | -10.932M -134.26% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.02 50.00% | -0.04 | 0.02 | 54.25% |
| Q2 2024 Q2Q % growth | -0.03 | -0.05 | 0.02 | 36.06% |
| Q1 2024 Q2Q % growth | -0.04 -33.33% | -0.04 | 0.00 | -2.31% |
| Q4 2023 Q2Q % growth | -0.03 | -0.04 | 0.01 | 31.38% |
| Q3 2023 Q2Q % growth | -0.04 | -0.04 | 0.00 | 8.50% |
| Q2 2023 Q2Q % growth | -0.03 25.00% | -0.05 | 0.02 | 33.59% |
| Q1 2023 Q2Q % growth | -0.03 25.00% | -0.04 | 0.01 | 23.27% |
| Q4 2022 Q2Q % growth | -0.03 82.35% | -0.04 | 0.01 | 20.81% |
| Q3 2022 Q2Q % growth | -0.04 20.00% | -0.04 | 0.00 | -12.04% |
| Q2 2022 Q2Q % growth | -0.04 -33.33% | -0.04 | 0.00 | 8.50% |
| Q1 2022 Q2Q % growth | -0.04 -300.00% | -0.03 | -0.01 | -15.34% |
| Q4 2021 Q2Q % growth | -0.17 -1,800.00% | -0.05 | -0.12 | -257.12% |
| Q3 2021 Q2Q % growth | -0.05 | -0.05 | 0.00 | -2.12% |
| Q2 2021 Q2Q % growth | -0.03 25.00% | -0.04 | 0.01 | 19.79% |
| Q1 2021 Q2Q % growth | -0.01 83.33% | -0.04 | 0.03 | 71.99% |
| Q4 2020 Q2Q % growth | 0.01 133.33% | -0.05 | 0.06 | 121.31% |
| Q3 2020 Q2Q % growth | -0.05 58.33% | -0.05 | 0.00 | -8.93% |
| Q2 2020 Q2Q % growth | -0.04 80.00% | -0.04 | 0.00 | 1.96% |
| Q1 2020 Q2Q % growth | -0.06 -120.00% | -0.05 | -0.01 | -22.55% |
| Q4 2019 Q2Q % growth | -0.03 90.63% | -0.05 | 0.02 | 43.44% |
| Q3 2019 Q2Q % growth | -0.12 -33.33% | -0.05 | -0.07 | -120.60% |
| Q2 2019 Q2Q % growth | -0.20 -566.67% | -0.05 | -0.15 | -277.07% |
| Q1 2019 Q2Q % growth | 0.30 160.00% | -0.06 | 0.36 | 574.38% |
| Q4 2018 Q2Q % growth | -0.32 | -0.07 | -0.25 | -364.78% |
| Q3 2018 Q2Q % growth | -0.09 | -0.07 | -0.02 | -26.05% |
| Q2 2018 Q2Q % growth | -0.03 | -0.08 | 0.05 | 60.78% |
| Q1 2018 Q2Q % growth | -0.50 | -0.07 | -0.43 | -576.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 3.779M 203.29% | 1.054M | 2.725M | 258.54% |
| Q2 2024 Q2Q % growth | 1.408M -56.34% | 988.635K | 419.365K | 42.42% |
| Q1 2024 Q2Q % growth | 1.444M -39.48% | 1.387M | 57K | 4.11% |
| Q4 2023 Q2Q % growth | 2.088M 8.75% | 1.336M | 752K | 56.29% |
| Q3 2023 Q2Q % growth | 1.246M -58.47% | 2.646M | -1.4M | -52.91% |
| Q2 2023 Q2Q % growth | 3.225M -29.12% | 2.241M | 984K | 43.91% |
| Q1 2023 Q2Q % growth | 2.386M -54.47% | 2.049M | 337K | 16.45% |
| Q4 2022 Q2Q % growth | 1.92M 64.10% | 2.617M | -697K | -26.63% |
| Q3 2022 Q2Q % growth | 3M 32.16% | 3.975M | -975K | -24.53% |
| Q2 2022 Q2Q % growth | 4.55M 792.16% | 3.758M | 792K | 21.08% |
| Q1 2022 Q2Q % growth | 5.24M 1,243.59% | 7.47M | -2.23M | -29.85% |
| Q4 2021 Q2Q % growth | 1.17M 225.00% | 856.8K | 313.2K | 36.55% |
| Q3 2021 Q2Q % growth | 2.27M 298.25% | 521.22K | 1.749M | 335.52% |
| Q2 2021 Q2Q % growth | 510K 30.77% | 418.2K | 91.8K | 21.95% |
| Q1 2021 Q2Q % growth | 390K -23.53% | 357K | 33K | 9.24% |
| Q4 2020 Q2Q % growth | 360K -70.97% | 939.93K | -579.93K | -61.70% |
| Q3 2020 Q2Q % growth | 570K | 438.6K | 131.4K | 29.96% |
| Q2 2020 Q2Q % growth | 390K -50.00% | 568.905K | -178.905K | -31.45% |
| Q1 2020 Q2Q % growth | 510K -45.16% | 656.88K | -146.88K | -22.36% |
| Q4 2019 Q2Q % growth | 1.24M 63.16% | 1.051M | 189K | 17.98% |
| Q3 2019 Q2Q % growth | 570K -41.84% | 824.497K | -254.497K | -30.87% |
| Q2 2019 Q2Q % growth | 780K -69.41% | 1.008M | -228K | -22.62% |
| Q1 2019 Q2Q % growth | 930K 32.86% | 760.512K | 169.488K | 22.29% |
| Q4 2018 Q2Q % growth | 760K | 599.25K | 160.75K | 26.83% |
| Q3 2018 Q2Q % growth | 980K | 696.997K | 283.003K | 40.60% |
| Q2 2018 Q2Q % growth | 2.55M | 567.63K | 1.982M | 349.24% |
| Q1 2018 Q2Q % growth | 700K | 721.14K | -21.14K | -2.93% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1366.8% | 0% | 14.47% |
| Revenue | 0% | -86.25% | 0% | -1.52% |